Shares in ASX eye diseases biotech Opthea Limited (ASX: OPT) remain frozen following a devastating update for investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback